U.S. Senate Finance Committee Ranking Member Ron Wyden (D-OR) has issued a release on the findings of his tax dodging investigation into Pfizer. One of the key findings is that Pfizer was able to declare zero taxable profits in the U.S. on USD 20 billion in U.S. sales in 2019 through the use of a round-tripping scheme. --- Wyden Unveils Findings of Pfizer Tax Dodging Investigation New Details of Pfizer Tax Avoidance Continue Wyden's Ongoing Tax Investigation of Big Pharma Washington, D.C. – Continuing his ongoing investigation of drug company tax avoidance, Senate Finance Committee Ranking Member Ron Wyden, D-Ore.,...